Moderna, Inc.
A biotechnology company that uses messenger RNA (mRNA) to build medicines and vaccines, best known for Spikevax, its COVID-19 vaccine. Founded in 2010 in Cambridge, Massachusetts, it grew out of the venture-building firm Flagship Pioneering with help from scientists including MIT's Robert Langer. Its name blends "modified" and "RNA"—and conveniently hides the word "modern."
Granted 9.3K · Sold 9.3K
Granted 118.0K · Sold 106.7K
Granted 44.2K · Sold 17.4K
Granted 28.6K
Granted 12.2K
Granted 16.2K
Granted 16.2K
Granted 16.2K · Sold 5.7K
Granted 8.1K
Granted 4.1K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Afeyan NoubarDirector · 2 transactions | — | 6.86M | 9.3K | — | 9.3K |
| Hoge StephenPresident · 12 transactions | +0.4% | 1.64M | 118.0K | — | 106.7K |
| Klinger Shannon ThymeChief Legal Officer · 14 transactions | +44.6% | 79.3K | 44.2K | — | 17.4K |
| Mock James MChief Financial Officer · 12 transactions | +40.2% | 71.4K | 28.6K | — | — |
| Nader FrancoisDirector · 1 transaction | +59.1% | 32.8K | 12.2K | — | — |
| Nabel Elizabeth GDirector · 1 transaction | +526.4% | 19.3K | 16.2K | — | — |
| Horning SandraDirector · 1 transaction | +690.2% | 18.6K | 16.2K | — | — |
| Hussain AbbasDirector · 2 transactions | +696.4% | 12.1K | 16.2K | — | 5.7K |
| Rubenstein David M.Director · 1 transaction | +531.5% | 9.6K | 8.1K | — | — |
| Tallett Elizabeth EDirector · 1 transaction | +577.2% | 4.8K | 4.1K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -139.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.